New York, NEW YORK (November 19, 2019) – The Global Coalition on Aging (GCOA) and Pfizer Global Medical Grants today officially launched a partnership to improve uptake of vaccines among Japanese older adults. Through $1 million USD in grant awards, the Vaccines for All: Longevity Unleashed for Everyone (VALUE) initiative will support, advance, and validate quality improvement strategies that measurably increase the number of older adults in Japan who are immunized against at least one targeted vaccine-preventable disease.

(New York & Tokyo, April 9, 2019) – Today, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) published a new report, The Impact of Innovation Across Technology, Health, Care and Urban Design for Super-Ageing Societies.

Your editorial “Japan’s Immigration Harbinger” (Dec. 6) correctly underscores the profound and potentially huge shift in Japan’s immigration policy to address “an aging society and [the related] labor shortage.”

Mr. Henderson notes Paul M. Romer’s ideas relating the structure of incentives to innovation using the profoundly crucial role patent policy has played in pharmaceutical innovation. But in the 21st century governments have countered the otherwise positive impact of patents with all manner of pharmaceutical price controls.